Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,572 | -3,823 | -3,225 | -3,852 | -811 |
| Depreciation Amortization | 1,307 | 2,255 | 861 | 561 | 259 |
| Accounts receivable | -11,039 | -3,118 | -2,179 | -1,462 | -829 |
| Accounts payable and accrued liabilities | 705 | 2,318 | 836 | 284 | 414 |
| Other Working Capital | -114 | -1,227 | 1,662 | 376 | -2,760 |
| Other Operating Activity | 12,803 | 4,564 | 3,779 | 2,875 | 1,254 |
| Operating Cash Flow | $2,090 | $969 | $1,734 | $-1,218 | $-2,473 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -26 | -14 | -14 | -14 |
| Net Acquisitions | N/A | -30,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -9,988 | -1,868 | -1,868 | -1,868 |
| Other Investing Activity | 0 | -9,988 | -1,868 | -1,868 | -1,868 |
| Investing Cash Flow | $N/A | $-40,014 | $-1,882 | $-1,882 | $-1,882 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 25,309 | N/A | N/A | N/A |
| Debt Repayment | N/A | -1,155 | -1,155 | -770 | -385 |
| Common Stock Issued | 394 | 8,439 | 176 | 176 | 7 |
| Financing Cash Flow | $394 | $32,593 | $-979 | $-594 | $-378 |
| Beginning Cash Position | 14,936 | 21,388 | 21,388 | 21,388 | 21,388 |
| End Cash Position | 17,420 | 14,936 | 20,261 | 17,694 | 16,655 |
| Net Cash Flow | $2,484 | $-6,452 | $-1,127 | $-3,694 | $-4,733 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,090 | 969 | 1,734 | -1,218 | -2,473 |
| Capital Expenditure | N/A | -26 | -14 | -14 | -14 |
| Free Cash Flow | 2,090 | 943 | 1,720 | -1,232 | -2,487 |